,
your personalized virtual assistant to find clinical trials. Go head, 
Joseph P. Lynch, MD
Natalie Warren Bryant Cancer Center ...Tulsa, Oklahoma - 74136 (918-494-8275) |
- CLINICAL TRIALS 15
- CONDITIONS25
- INTERVENTIONS35
- SINCE2004
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
July 2005 - October 2012
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011
Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
May 2008 - February 2009
Capecitabine Gemcitabine and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
December 2008 - December 2010
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma Acral Melanoma or Solar Melanoma That Cannot Be Removed By Surgery
May 2009 - March 2013
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
July 2009 - December 2010
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
July 2004 -
Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
September 2009 - January 2011
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma, Non-Small-Cell Lung
Melanoma
Carcinoma, Small Cell
Colorectal Neoplasms
Carcinoma, Transitional Cell
Cholangiocarcinoma
Gallbladder Neoplasms
Bile Duct Neoplasms
Ureteral Neoplasms
Urologic Neoplasms
Urethral Neoplasms
Placebo
Intensity-Modulated Radiation Therapy
Zoledronic Acid
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Dasatinib
Gemcitabine Hydrochloride
Adjuvant Therapy
Cyclophosphamide
Pemetrexed Disodium
Capecitabine
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Doxorubicin Hydrochloride
Temsirolimus
Cixutumumab
Sorafenib Tosylate
Cetuximab
Biologic Sample Preservation Procedure
Tamoxifen Citrate
Irinotecan Hydrochloride
Etoposide Phosphate
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Letrozole
Ac Regimen
Chemotherapy
Hedgehog Antagonist Gdc-0449
Vinorelbine Ditartrate
Placebo Administration
